comparemela.com
Home
Live Updates
Sumitomo Pharma Oncology Receives Orphan Drug Designation fo
Sumitomo Pharma Oncology Receives Orphan Drug Designation fo
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia
/PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food and Drug...
Related Keywords
United States ,
China ,
Japan ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Jatinj Shah ,
Huax Menin ,
Patricias Andrews ,
,
Prnewswire Sumitomo Pharma Oncology Inc ,
Sumitomo Pharma Co Ltd ,
Drug Administration ,
Sumitomo Pharma Oncology Inc ,
Pharma Oncology ,
Orphan Drug Designation ,
Global Head ,
Sumitomo Pharma Oncology ,
Drug Designation ,
Chief Medical Officer ,
Private Securities Litigation Reform Act ,
Myeloid Leukemia ,
Updated July ,
Future Med ,
Nc ,